+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Assisted Reproductive Technology Global Market Opportunities and Strategies to 2033

  • PDF Icon

    Report

  • 393 Pages
  • July 2024
  • Region: Global
  • The Business Research Company
  • ID: 5982227
This report describes and explains the assisted reproductive technology market and covers 2018-2023, termed the historic period, and 2023-2028, 2033F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.

The global assisted reproductive technology market reached a value of nearly $37.6 billion in 2023, having grown at a compound annual growth rate (CAGR) of 5.6% since 2018. The market is expected to grow from $37.6 billion in 2023 to $55.91 billion in 2028 at a rate of 8.3%. The market is then expected to grow at a CAGR of 8.4% from 2028 and reach $83.8 billion in 2033.

Growth in the historic period resulted from the increasing prevalence of PCOS (polycystic ovary syndrome), growing trend of late parenthood, increase in same-sex couples, rise in male infertility and increased healthcare expenditure. Factors that negatively affected growth in the historic period were high cost of fertility services and low success rates of IVF.

Going forward, the technological developments, growing prevalence of obesity, rising number of infertility cases, increasing government initiatives and funding and rise in disposable income will drive the market. Factors that could hinder the growth of the assisted reproductive technology market in the future include stringent government policies and high cost of treatment.

The assisted reproductive technology (ART) market is segmented by technology into in vitro-fertilization (IVF), artificial insemination (AI-IUI) and other technologies. The in vitro-fertilization (IVF) market was the largest segment of the assisted reproductive technology (ART) market segmented by technology, accounting for 83.2% or $26.12 billion of the total in 2023. Going forward, the artificial insemination (AI-IUI) segment is expected to be the fastest growing segment in the assisted reproductive technology (ART) market segmented by technology, at a CAGR of 10.4% during 2023-2028.

The assisted reproductive technology (ART) market is segmented by procedure type into fresh non-donor, fresh donor, frozen donor, frozen non-donor and embryo or egg banking. The fresh non-donor market was the largest segment of the assisted reproductive technology (ART) market segmented by procedure type, accounting for 48.5% or $15.22 billion of the total in 2023. Going forward, the embryo or egg banking segment is expected to be the fastest growing segment in the assisted reproductive technology (ART) market segmented by procedure type, at a CAGR of 10.7% during 2023-2028.

The assisted reproductive technology market is segmented by end-user into hospitals, fertility clinics and other end-users. The fertility clinics market was the largest segment of the assisted reproductive technology market segmented by end-user, accounting for 48% or $18.06 billion of the total in 2023. Going forward, the fertility clinics segment is expected to be the fastest growing segment in the assisted reproductive technology market segmented by end-user, at a CAGR of 9% during 2023-2028.

The assisted reproductive technology (ART) testing market is segmented by ART testing/diagnosis into in ovulation testing, hysterosalpingography, ovarian reserve testing, genetic testing and other tests. The other tests market was the largest segment of the assisted reproductive technology (ART) testing market segmented by ART testing/diagnosis, accounting for 33.3% or $2.07 billion of the total in 2023. Going forward, the other tests segment is expected to be the fastest growing segment in the assisted reproductive technology (ART) testing market segmented by ART testing/diagnosis, at a CAGR of 6.6% during 2023-2028.

The other tests market is segmented by ART diagnosis/testing into in computer assisted semen analysis (CASA), sperm penetration assay, microscopic examination and others testing/diagnosis. The computer assisted semen analysis (CASA) market was the largest segment of the assisted reproductive technology market segmented by ART testing/diagnosis, accounting for 52.4% or $1.08 billion of the total in 2023. Going forward, the sperm penetration assay segment is expected to be the fastest growing segment in the assisted reproductive technology market segmented by ART testing/diagnosis, at a CAGR of 8.5% during 2023-2028.

North America was the largest region in the assisted reproductive technology market, accounting for 34.9% or $10.95 billion of the total in 2023. It was followed by Western Europe, Asia-Pacific and then the other regions. Going forward, the fastest-growing regions in the assisted reproductive technology market will be Asia-Pacific and North America, where growth will be at CAGRs of 6.4% and 6.1% respectively. These will be followed by Western Europe and South America, where the markets are expected to grow at CAGRs of 5.6% and 5.3% respectively.

The global assisted reproductive technology market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 17.9% of the total market in 2022. Vitrolife was the largest competitor with a 9.8% share of the market, followed by Ferring B.V. with 3.7%, Progyny Inc. with 1.5%, CooperSurgical Inc. with 1.2%, FUJIFILM Irvine Scientific, Inc. with 1.1%, Monash IVF Group with 0.4%, Hamilton Thorne Inc. with 0.2%, Genea Limited with 0.1%, IVI-RMA with 0.01% and Bloom IVF Centre with 0.01%.

The top opportunities in the assisted reproductive technology (ART) market segmented by technology will arise in the in vitro-fertilization (IVF) segment, which will gain $13.22 billion of global annual sales by 2028. The top opportunities in the assisted reproductive (ART) technology market segmented by procedure type will arise in the fresh non-donor segment, which will gain $8.01 billion of global annual sales by 2028. The top opportunities in the assisted reproductive technology market segmented by end-user will arise in the fertility clinics segment, which will gain $9.73 billion of global annual sales by 2028. The top opportunities in the assisted reproductive technology (ART) testing market segmented by ART testing/diagnosis will arise in the other tests segment, which will gain $785.5 million of global annual sales by 2028. The top opportunities in the other tests market segmented by ART testing/diagnosis will arise in the computer assisted semen analysis (CASA) segment, which will gain $430.6 million of global annual sales by 2028. The assisted reproductive technology market size will gain the most in the USA at $4.55 billion.

Market-trend-based strategies for the assisted reproductive technology market include key players launching innovative programs to promote art and support sustainability, impact of artificial intelligence on assisted reproductive technology, advanced technological solutions in assisted reproductive technology, blockchain integration in assisted reproductive technology, strategic collaborations driving innovation in assisted reproductive technology and innovative fertility treatment options to enhance access to care.

Player-adopted strategies in the assisted reproductive technology market include focus on expanding business expertise through strategic acquisitions and strategic partnerships, strengthening business capabilities through new product platforms, enhancing business operations through new product developments and strengthening business capabilities through new product launches.

To take advantage of the opportunities, the analyst recommends the assisted reproductive technology companies to focus on tailored organoid solutions for biotherapeutic research, focus on advanced technological solutions for enhanced fertility, focus on integrating ai for enhanced IVF treatment, focus on innovative fertility treatment options, focus on IVF (in vitro-fertilization) and AI-IUI (artificial insemination) segments, focus on fresh non-donor and embryo or egg banking segments, expand in emerging markets, continue to focus on developed markets, focus on strategic collaborations for enhanced IVF processes, provide competitively priced offerings, continue to use B2B promotions, focus on innovative patient-centric initiatives and focus on fertility clinics segment.

Table of Contents

1 Executive Summary
1.1 Assisted Reproductive Technology - Market Attractiveness and Macro economic Landscape
2 Table of Contents3 List of Tables4 List of Figures5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 Assisted Reproductive Technology Market Definition and Segmentations
6.4 Market Segmentation by Technology
6.4.1 in Vitro-Fertilization (IVF)
6.4.2 Artificial Insemination (AI-IUI)
6.4.3 Other Technologies
6.5 Market Segmentation by Procedure Type
6.5.1 Fresh Non-Donor
6.5.2 Fresh Donor
6.5.3 Frozen Donor
6.5.4 Frozen Non-Donor
6.5.5 Embryo Or Egg Banking
6.6 Market Segmentation by End-User
6.6.1 Hospitals
6.6.2 Fertility Clinics
6.6.3 Other End-Users
6.7 Market Segmentation by Diagnosis/Testing
6.7.1 Ovulation Testing
6.7.2 Hysterosalpingography
6.7.3 Ovarian Reserve Testing
6.7.4 Genetic Testing
6.7.5 Other Test
6.7.5.1 Computer Assisted Semen Analysis
6.7.5.2 Sperm Penetration Assay
6.7.5.3 Microscopic Examination
6.7.5.4 Others Testing/Diagnosis
7 Major Market Trends
7.1 Key Players Launching Innovative Programs to Promote ART and Support Sustainability
7.2 Impact of Artificial Intelligence on Assisted Reproductive Technology
7.3 Advanced Technological Solutions in Assisted Reproductive Technology
7.4 Blockchain Integration in Assisted Reproductive Technology
7.5 Strategic Collaborations Driving Innovation in Assisted Reproductive Technology
7.6 Innovative Fertility Treatment Options to Enhance Access to Care
8 Assisted Reproductive Technology Market - Macro Economic Scenario
8.1 COVID-19 Impact on the Assisted Reproductive Technology Market
8.2 Impact of the War in Ukraine on the Assisted Reproductive Technology Market
8.3 Impact of High Inflation on the Assisted Reproductive Technology Market
9 Global Market Size and Growth
9.1 Market Size
9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
9.2.1 Market Drivers 2018 - 2023
9.2.2 Market Restraints 2018 - 2023
9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
9.3.1 Market Drivers 2023 - 2028
9.3.2 Market Restraints 2023 - 2028
10 Global Assisted Reproductive Technology Market Segmentation
10.1 Global Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.2 Global Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.3 Global Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.4 Global Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.4.1 Global Other Tests Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11 Assisted Reproductive Technology Market, Regional and Country Analysis
11.1 Global Assisted Reproductive Technology Market, by Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.2 Global Assisted Reproductive Technology Market, by Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12 Asia-Pacific Market
12.1 Summary
12.1.1 Market Overview
12.1.2 Region Information
12.1.3 Market Information
12.1.4 Background Information
12.1.5 Government Initiatives
12.1.6 Regulations
12.1.7 Regulatory Bodies
12.1.8 Major Associations
12.1.9 Taxes Levied
12.1.10 Corporate Tax Structure
12.1.11 Investments
12.1.12 Major Companies
12.2 Asia-Pacific Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.3 Asia-Pacific Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.4 Asia-Pacific Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.6 Asia-Pacific Assisted Reproductive Technology Market: Country Analysis
12.7 China Market
12.8 Summary
12.8.1 Market Overview
12.8.2 Country Information
12.8.3 Market Information
12.8.4 Background Information
12.8.5 Government Initiatives
12.8.6 Regulations
12.8.7 Regulatory Bodies
12.8.8 Major Associations
12.8.9 Taxes Levied
12.8.10 Corporate Tax Structure
12.8.11 Investments
12.8.12 Major Companies
12.9 China Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.10 China Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.11 China Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.12 China Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.13 India Market
12.14 India Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.15 India Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.16 India Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.17 India Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.18 Japan Market
12.19 Japan Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.20 Japan Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.21 Japan Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.22 Japan Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.23 Australia Market
12.24 Australia Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.25 Australia Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.26 Australia Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.27 Australia Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.28 Indonesia Market
12.29 Indonesia Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.30 Indonesia Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.31 Indonesia Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.32 Indonesia Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.33 South Korea Market
12.34 South Korea Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.35 South Korea Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.36 South Korea Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.37 South Korea Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13 Western Europe Market
13.1 Summary
13.1.1 Market Overview
13.1.2 Region Information
13.1.3 Market Information
13.1.4 Background Information
13.1.5 Government Initiatives
13.1.6 Regulations
13.1.7 Regulatory Bodies
13.1.8 Major Associations
13.1.9 Taxes Levied
13.1.10 Corporate Tax Structure
13.1.11 Investments
13.1.12 Major Companies
13.2 Western Europe Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.3 Western Europe Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.5 Western Europe Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.6 Western Europe Assisted Reproductive Technology Market: Country Analysis
13.7 UK Market
13.8 UK Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.9 UK Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.10 UK Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.11 UK Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.12 Germany Market
13.13 Germany Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.14 Germany Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.15 Germany Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.16 Germany Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.17 France Market
13.18 France Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.19 France Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.20 France Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.21 France Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.22 Italy Market
13.23 Italy Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.24 Italy Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.25 Italy Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.26 Italy Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.27 Spain Market
13.28 Spain Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.29 Spain Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.30 Spain Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.31 Spain Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14 Eastern Europe Market
14.1 Summary
14.1.1 Market Overview
14.1.2 Region Information
14.1.3 Market Information
14.1.4 Background Information
14.1.5 Government Initiatives
14.1.6 Regulations
14.1.7 Regulatory Bodies
14.1.8 Major Associations
14.1.9 Taxes Levied
14.1.10 Corporate Tax Structure
14.1.11 Investments
14.1.12 Major Companies
14.2 Eastern Europe Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.3 Eastern Europe Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.6 Eastern Europe Assisted Reproductive Technology Market: Country Analysis
14.7 Russia Market
14.8 Russia Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.9 Russia Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.10 Russia Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.11 Russia Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15 North America Market
15.1 Summary
15.1.1 Market Overview
15.1.2 Region Information
15.1.3 Market Information
15.1.4 Background Information
15.1.5 Government Initiatives
15.1.6 Regulations
15.1.7 Regulatory Bodies
15.1.8 Major Associations
15.1.9 Taxes Levied
15.1.10 Corporate Tax Structure
15.1.11 Investments
15.1.12 Major Companies
15.2 North America Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.3 North America Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.4 North America Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.5 North America Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.6 North America Assisted Reproductive Technology Market: Country Analysis
15.7 USA Market
15.8 Summary
15.8.1 Market Overview
15.8.2 Country Information
15.8.3 Market Information
15.8.4 Background Information
15.8.5 Government Initiatives
15.8.6 Regulations
15.8.7 Regulatory Bodies
15.8.8 Major Associations
15.8.9 Taxes Levied
15.8.10 Corporate Tax Structure
15.8.11 Investments
15.8.12 Major Companies
15.9 USA Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.10 USA Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.11 USA Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.12 USA Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.13 Canada Market
15.14 Canada Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.15 Canada Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.16 Canada Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.17 Canada Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16 South America Market
16.1 Summary
16.1.1 Market Overview
16.1.2 Region Information
16.1.3 Market Information
16.1.4 Background Information
16.1.5 Government Initiatives
16.1.6 Regulations
16.1.7 Regulatory Bodies
16.1.8 Major Associations
16.1.9 Taxes Levied
16.1.10 Corporate Tax Structure
16.1.11 Investments
16.1.12 Major Companies
16.2 South America Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.3 South America Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.4 South America Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.5 South America Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.6 South America Assisted Reproductive Technology Market: Country Analysis
16.7 Brazil Market
16.8 Brazil Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.10 Brazil Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.11 Brazil Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17 Middle East Market
17.1 Summary
17.1.1 Market Overview
17.1.2 Region Information
17.1.3 Market Information
17.1.4 Background Information
17.1.5 Government Initiatives
17.1.6 Regulations
17.1.7 Regulatory Bodies
17.1.8 Major Associations
17.1.9 Taxes Levied
17.1.10 Corporate Tax Structure
17.1.11 Investments
17.1.12 Major Companies
17.2 Middle East Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.3 Middle East Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.5 Middle East Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18 Africa Market
18.1 Summary
18.1.1 Market Overview
18.1.2 Region Information
18.1.3 Market Information
18.1.4 Background Information
18.1.5 Government Initiatives
18.1.6 Regulations
18.1.7 Regulatory Bodies
18.1.8 Major Associations
18.1.9 Taxes Levied
18.1.10 Corporate Tax Structure
18.1.11 Investments
18.1.12 Major Companies
18.2 Africa Assisted Reproductive Technology (ART) Market, Segmentation by Technology, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.3 Africa Assisted Reproductive Technology (ART) Market, Segmentation by Procedure Type, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.4 Africa Assisted Reproductive Technology Market, Segmentation by End-User, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.5 Africa Assisted Reproductive Technology (ART) Testing Market, Segmentation by ART Testing/Diagnosis, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
19 Competitive Landscape and Company Profiles
19.1 Vitrolife AB
19.1.1 Company Overview
19.1.2 Products and Services
19.1.3 Business Strategy
19.1.4 Financial performance
19.2 Ferring B.V.
19.2.1 Company Overview
19.2.2 Products and Services
19.2.3 Business Strategy
19.2.4 Financial performance
19.3 Progyny Inc.
19.3.1 Company Overview
19.3.2 Products and Services
19.3.3 Business Strategy
19.3.4 Financial Performance
19.4 CooperSurgical Inc.
19.4.1 Company Overview
19.4.2 Products and Services
19.4.3 Business Strategy
19.4.4 Financial Overview
19.5 FUJIFILM Irvine Scientific, Inc.
19.5.1 Company Overview
19.5.2 Products and Services
19.5.3 Business Strategy
19.5.4 Financial Overview
20 Competitive Benchmarking21 Competitive Dashboard
22 Key Mergers and Acquisitions
22.1 Hamilton Thorne Acquired Gynetics Medical Products
22.2 Reproductive Medicine Associates (RMA) and IVI-RMA Acquired Conceptions Reproductive Associates of Colorado
22.3 BPEA EQT Acquired Indira IVF
22.4 Calibre Scientific Acquired Microm UK Limited and Scopescreen
22.5 Liverpool Partners Acquired Genea Ltd.
23 Opportunities and Strategies
23.1 Global Assisted Reproductive Technology Market in 2028 - Countries Offering Most New Opportunities
23.2 Global Assisted Reproductive Technology Market in 2028 - Segments Offering Most New Opportunities
23.3 Global Assisted Reproductive Technology Market in 2028 - Growth Strategies
23.3.1 Market Trend Based Strategies
23.3.2 Competitor Strategies
24 Assisted Reproductive Technology Market, Conclusions and Recommendations
24.1 Conclusions
24.2 Recommendations
24.2.1 Product
24.2.2 Place
24.2.3 Price
24.2.4 Promotion
24.2.5 People
25 Appendix
25.1 Geographies Covered
25.2 Market Data Sources
25.3 Research Methodology
25.4 Currencies
25.5 About the Analyst
25.6 Copyright and Disclaimer

Executive Summary

Assisted Reproductive Technology Global Market Opportunities and Strategies to 2033 provides the strategists; marketers and senior management with the critical information they need to assess the global assisted reproductive technology market as it emerges from the COVID-19 shut down.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description

Where is the largest and fastest-growing market for assisted reproductive technology? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The assisted reproductive technology market global report answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider assisted reproductive technology market; and compares it with other markets.

The report covers the following chapters:

  • Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by technology, by diagnosis/testing, by procedure type and by end-user.
  • Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario - The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the assisted reproductive technology market.
  • Global Market Size and Growth - Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional and Country Analysis - Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation - Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by technology, by diagnosis/testing, by procedure type and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth - Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard - Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions - Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities and Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions and Recommendations - This section includes recommendations for assisted reproductive technology providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) by Technology: in Vitro-Fertilization (IVF); Artificial Insemination (AI-IUI); Other Technologies
2) by Procedure Type: Fresh Non-Donor; Fresh Donor; Frozen Donor; Frozen Non-Donor; Embryo or Egg Banking
3) by End-User: Hospitals; Fertility Clinics; Other End-Users
4) by Testing/Diagnosis: in Ovulation Testing; Hysterosalpingography; Ovarian Reserve Testing; Genetic Testing; Other Tests

Key Companies Mentioned: Vitrolife; Ferring B.V.; Progyny Inc.; CooperSurgical Inc.; FUJIFILM Irvine Scientific, Inc.

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; assisted reproductive technology indicators comparison.

Data Segmentation: Country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Vitrolife
  • Ferring B.V.
  • Progyny Inc.
  • CooperSurgical Inc.
  • FUJIFILM Irvine Scientific, Inc.
  • Monash IVF Group
  • Hamilton Thorne Inc.
  • Genea Limited
  • IVI-RMA
  • Bloom IVF Centre
  • Jinxin Fertility Group Limited
  • Amcare
  • Beijing United Family Hospital
  • Reproductive & Genetic Hospital CITIC-XIANGYA
  • OvaScience Shanghai
  • Shanghai Ji Ai Genetics & IVF Institute
  • Guangzhou Women and Children's Medical Center
  • Shenzhen Zhongshan Urology Hospital
  • Shanghai Ninth People's Hospital
  • Nova IVI Fertility
  • Manipal Fertility
  • Indira IVF
  • Milann
  • Origio Japan K.K
  • Eizai
  • Konica Minolta Healthcare
  • Fuso Pharmaceutical Industries, Ltd
  • Tokai Hit
  • IVF Korea
  • CHA Fertility Center
  • Fertility Center of CHA Gangnam Medical Center
  • Virtus Health
  • Fertility First
  • Queensland Fertility Group
  • Morula IVF
  • PrimaNest
  • Hermina IVF Center
  • Fertility Clinic Jakarta
  • EUGIN Group
  • Clinique de la Muette
  • FIV Paris-Nord
  • IVI Clinic
  • Groupe NATEC Medical
  • Medistim
  • Medfem Clinic
  • StorkKlinik
  • Fertility Center Berlin
  • Barcelona IVF
  • Instituto Bernabeu
  • Ginemed
  • Livio Fertilitetscentrum
  • Stockholm IVF
  • Gothenburg University Hospital
  • Västerås Hospital
  • Uppsala University Hospital
  • Fertility Clinic GENEVA
  • Swiss Fertility Center
  • Kinderwunschzentrum Zürich
  • Basel Fertility Clinic
  • Lausanne Fertility Clinic
  • Reprogenetics Italia
  • Bologna Fertility Center
  • Roma Fertility Clinic
  • Naples Fertility Clinic
  • Milan Fertility Clinic
  • Care Fertility Group
  • The Lister Fertility Clinic
  • Create Fertility
  • London Women's Clinic
  • Manchester Fertility
  • European Medical Center (EMC)
  • Nova Clinic
  • IVI Russia
  • MD Medical Group
  • Mother and Child
  • MedLife
  • Regina Maria
  • Fertilia Clinic
  • Biogenis Clinic
  • Genesys Fertility Center
  • INVICTA Fertility Clinics
  • InviMed
  • Gyncentrum
  • VitroLive
  • Fertility Clinic AVA
  • IVF Cube
  • Prague Fertility Centre
  • IVF Zlin
  • IVF ReproGenesis
  • Fertimed
  • Future Fertility
  • IVI RMA
  • US Fertility LLC
  • Ovation Fertility
  • INVO Bioscience Inc.
  • Wisconsin Fertility Institute
  • Alife Health
  • Cook Medical
  • Shady Grove Fertility
  • Cooper Surgical Inc.
  • FertGroup
  • Huntington Medicina Reprodutiva
  • San Isidro Medicina
  • Fertipraxis
  • Oya Care
  • AIVF
  • Gargash Hospital
  • Medfem Fertility Clinic
  • VitaLab Fertility Clinic
  • Cape Fertility Clinic
  • Fertility Clinic Johannesburg
  • Sandton Fertility Clinic
  • The Bridge Clinic
  • George's Memorial Medical Centre
  • Mart Life Detox Clinic
  • Rivers State University Teaching Hospital (RSUTH)
  • St. Ives Specialist Hospital
  • Nairobi IVF Centre
  • Avenue Healthcare Fertility Centre
  • Mediheal Group of Hospitals
  • The Nairobi Hospital
  • Family Fertility Centre
  • Fertility Options
  • IVF Uganda
  • Women's Hospital International and Fertility Centre
  • Dr. Salah Dawood Clinic
  • Cairo Fertility Clinic
  • Nile Fertility Center
  • Assiut University Hospital
  • Alfa Medical Centre

Methodology

Loading
LOADING...

Table Information